» Articles » PMID: 33994947

Transplantation of Human Cortically-Specified Neuroepithelial Progenitor Cells Leads to Improved Functional Outcomes in a Mouse Model of Stroke

Overview
Specialty Cell Biology
Date 2021 May 17
PMID 33994947
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is a leading cause of death and long-term disability worldwide. Current therapeutic options are limited in terms of their time for implementation and efficacy in promoting recovery. Cell transplantation has been shown to have promise in several animal models however significant challenges remain, including the optimal source of cells to promote neural repair. Here, we report on the use of a population of human ESC derived, cortically specified, neuroepithelial precursor cells (cNEPs) that are neurally restricted in their lineage potential. CNEPs have the potential to give rise to mature neural cell types following transplantation, including neurons, astrocytes and oligodendrocytes. With a view towards translation, we sought to determine whether this human cell source was effective in promoting improved functional outcomes following stroke. Undifferentiated cNEPs were transplanted in a pre-clinical endothelin-1 (ET-1) model of ischemic motor cortical stroke in immunocompromised SCID-beige mice and cellular and functional outcomes were assessed. We demonstrate that cNEP transplantation in the acute phase (4 days post-stroke) improves motor function as early as 20 days post-stroke, compared to stroke-injured, non-transplanted mice. At the time of recovery, a small fraction (<6%) of the transplanted cNEPs are observed within the stroke injury site. The surviving cells expressed the immature neuronal marker, doublecortin, with no differentiation into mature neural phenotypes. At longer survival times (40 days), the majority of recovered, transplanted mice had a complete absence of surviving cNEPS. Hence, human cNEPs grafted at early times post-stroke support the observed functional recovery following ET-1 stroke but their persistence is not required, thereby supporting a by-stander effect rather than cell replacement.

Citing Articles

Primitive and Definitive Neural Precursor Cells Are Present in Human Cerebral Organoids.

Islam R, Noman H, Azimi A, Siu R, Chinchalongporn V, Schuurmans C Int J Mol Sci. 2024; 25(12).

PMID: 38928255 PMC: 11203442. DOI: 10.3390/ijms25126549.


An update on stem cell therapy for stroke patients: Where are we now?.

Gordon J, Borlongan C J Cereb Blood Flow Metab. 2024; 44(9):1469-1479.

PMID: 38639015 PMC: 11418600. DOI: 10.1177/0271678X241227022.


Inhibition of Apoptosis in a Model of Ischemic Stroke Leads to Enhanced Cell Survival, Endogenous Neural Precursor Cell Activation and Improved Functional Outcomes.

Islam R, Ahlfors J, Siu R, Noman H, Akbary R, Morshead C Int J Mol Sci. 2024; 25(3).

PMID: 38339065 PMC: 10855341. DOI: 10.3390/ijms25031786.


The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease.

Gordon J, Lockard G, Monsour M, Alayli A, Borlongan C Antioxidants (Basel). 2022; 11(8).

PMID: 35892653 PMC: 9332234. DOI: 10.3390/antiox11081447.


Neuroinflammation, Stem Cells, and Stroke.

Anthony S, Cabantan D, Monsour M, Borlongan C Stroke. 2022; 53(5):1460-1472.

PMID: 35380050 PMC: 9038685. DOI: 10.1161/STROKEAHA.121.036948.

References
1.
Forsberg M, Kink J, Hematti P, Capitini C . Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol. 2020; 8:665. PMC: 7379234. DOI: 10.3389/fcell.2020.00665. View

2.
Liang Q, Monetti C, Shutova M, Neely E, Hacibekiroglu S, Yang H . Linking a cell-division gene and a suicide gene to define and improve cell therapy safety. Nature. 2018; 563(7733):701-704. DOI: 10.1038/s41586-018-0733-7. View

3.
Guillaume D, Johnson M, Li X, Zhang S . Human embryonic stem cell-derived neural precursors develop into neurons and integrate into the host brain. J Neurosci Res. 2006; 84(6):1165-76. PMC: 2735209. DOI: 10.1002/jnr.21022. View

4.
Wakabayashi K, Nagai A, Sheikh A, Shiota Y, Narantuya D, Watanabe T . Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res. 2009; 88(5):1017-25. DOI: 10.1002/jnr.22279. View

5.
Ballios B, Cooke M, Donaldson L, Coles B, Morshead C, van der Kooy D . A Hyaluronan-Based Injectable Hydrogel Improves the Survival and Integration of Stem Cell Progeny following Transplantation. Stem Cell Reports. 2015; 4(6):1031-45. PMC: 4471829. DOI: 10.1016/j.stemcr.2015.04.008. View